Catalyst Wire Dossier Catalyst Wire Dossier

WX-081 (Sudapyridine)

Sudapyridine · Shanghai Jiatan Pharmatech Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WX-081 (Sudapyridine), covering 2024-11-22 to 2024-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of Sudapyridine(WX-081)in Healthy Chinese Subjects [Phase 1]

See pricing